Overactive bladder drugs on SilverScript Choice (S5601-008)
Oxybutynin, solifenacin, Myrbetriq and Gemtesa, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), New Jersey
- Premium
- $97.40/month
- Deductible
- $615.00
6 of 7 Overactive bladder drugs are covered on this plan. None require prior authorization.
1 isn't on the formulary (mirabegron).
- $7.00Tier 2
- $7.00Tier 2
- from $81.53Tier 3
- $93.61Tier 3
- from $10.48Tier 4
- from $7.00Tier 2
Not on the formulary
mirabegron
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.